08-30-2023-1913 - draft (LONG-ACTING NANOFORMULATIONS REDUCE DOLUTEGRAVIR EXPOSURE TO EMBRYO BRAIN, croiconference, etc., draft)

LONG-ACTING NANOFORMULATIONS REDUCE DOLUTEGRAVIR EXPOSURE TO EMBRYO BRAIN

https://www.croiconference.org/abstract/long-acting-nanoformulations-reduce-dolutegravir-exposure-to-embryo-brain/